• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of superficial (T1) tumours of the bladder by radical radiotherapy.

作者信息

Quilty P M, Duncan W

出版信息

Br J Urol. 1986 Apr;58(2):147-52. doi: 10.1111/j.1464-410x.1986.tb09015.x.

DOI:10.1111/j.1464-410x.1986.tb09015.x
PMID:3083903
Abstract

Local tumour control and survival is reported for 190 patients with T1 transitional cell cancer of the bladder who received a radical course of X-ray therapy. There was no difference in survival by the histological grade of the cancer but patients with grade 3 cancers had the highest probability of local control. After initial complete local tumour regression there was a similar probability of subsequent distant metastases irrespective of the grade of the cancer. Radical small field beam directed radiotherapy is commended for patients with T1/pT1 grade 3 transitional cell cancer of the bladder.

摘要

相似文献

1
Treatment of superficial (T1) tumours of the bladder by radical radiotherapy.
Br J Urol. 1986 Apr;58(2):147-52. doi: 10.1111/j.1464-410x.1986.tb09015.x.
2
The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.对963例膀胱移行细胞癌患者进行根治性兆伏级X线治疗的一系列结果。
Radiother Oncol. 1986 Dec;7(4):299-310. doi: 10.1016/s0167-8140(86)80059-7.
3
Split-course radiotherapy for urinary bladder cancer.
Radiother Oncol. 1989 Aug;15(4):327-31. doi: 10.1016/0167-8140(89)90078-9.
4
Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy.膀胱癌的预后指标:对主要接受根治性兆伏级X线治疗的膀胱移行细胞癌患者的分析
Radiother Oncol. 1986 Dec;7(4):311-21. doi: 10.1016/s0167-8140(86)80060-3.
5
Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy?正常黏膜活检能否预测接受根治性放疗的膀胱移行细胞癌患者的预后?
Br J Urol. 1987 Mar;59(3):242-7. doi: 10.1111/j.1464-410x.1987.tb04615.x.
6
Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.顺铂与多西他赛同步化疗联合外照射根治性放疗用于浸润性移行细胞膀胱癌患者:耐受性及局部控制的初步报告
Anticancer Res. 1997 Nov-Dec;17(6D):4771-80.
7
Results of implantation for T1 and T2 bladder tumours.T1和T2期膀胱肿瘤的植入结果。
Radiother Oncol. 1986 Feb;5(2):85-90. doi: 10.1016/s0167-8140(86)80161-x.
8
The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer.
Semin Urol Oncol. 1997 Aug;15(3):161-8.
9
The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation.血红蛋白水平对膀胱移行细胞癌光子照射后消退及长期局部控制的影响。
Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1735-42. doi: 10.1016/0360-3016(86)90313-5.
10
Predicting the outcome of radical radiotherapy for invasive bladder cancer.预测浸润性膀胱癌根治性放疗的结果。
Eur Urol. 1993;24(1):48-51. doi: 10.1159/000474261.

引用本文的文献

1
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.保留膀胱的三联疗法治疗高级别 T1 膀胱癌:NRG 肿瘤学/RTOG 0926 Ⅱ期方案的结果。
J Clin Oncol. 2024 Dec;42(34):4095-4102. doi: 10.1200/JCO.23.02510. Epub 2024 Sep 3.
2
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.美国国立癌症研究所非肌层浸润性膀胱癌新型疗法临床试验规划会议的总结与建议
Bladder Cancer. 2016 Apr 27;2(2):165-202. doi: 10.3233/BLC-160053.
3
Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.
专家共识文件:关于膀胱癌卡介苗膀胱内免疫治疗应用的最佳实践管理的共识声明。
Nat Rev Urol. 2015 Apr;12(4):225-35. doi: 10.1038/nrurol.2015.58. Epub 2015 Mar 24.
4
The optimal management of T1 high-grade bladder cancer.T1期高级别膀胱癌的最佳管理
Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S188-92.